Lumigan (bimatoprost ophthalmic) eye drops are an FDA-approved ophthalmic solution used to treat cases of high intraocular pressure (IOP) commonly associated with conditions such as open-angle glaucoma or ocular hypertension. The medicated eye...
Latisse is an ophthalmic solution containing the active ingredient bimatoprost. Its manufacturer Allergan originally produced bimatoprost as the brand Lumigan for treating glaucoma. This product turned out to have a positive side effect, as it...
Long, lush lashes are a symbol of beauty and femininity. Throughout history, people have used various methods to enhance the look of their eyelashes. However, only recently has science found a way to change the actual growth pattern of eyelashes....
The average scalp has about 100,000 hairs, and most people lose about 100 hairs each day, according to MedlinePlus, a service of the U.S. National Library of Medicine. Alopecia is the thinning or complete loss of hair that occurs in men, women and...
Glaucoma is not a distinct disorder. It is a combination of conditions that cause ocular damage. The damage is gradual. The primary factor in the development of glaucoma is the increase intraocular pressure, or pressure in the eye. Glaucoma is the...
The first eyelash growth treatment backed by scientific study and clinical trials was approved by the U.S. Food & Drug Administration in December 2008. The active ingredient used by Allergan, bimatoprost, is featured in the topical eyelash...
Luscious, lustrous, thick, dark eyelashes are the envy of women all over the world. The longer and thicker your eyelashes, the bigger and brighter your eyes look---and the younger you look. No wonder products that promise to enhance or stimulate...
